Evercore ISI Group Maintains In-Line on Zimmer Biomet Holdings, Lowers Price Target to $104

Zimmer Biomet Holdings, Inc. +1.20%

Zimmer Biomet Holdings, Inc.

ZBH

94.28

+1.20%

Evercore ISI Group analyst Vijay Kumar maintains Zimmer Biomet Holdings (NYSE: ZBH) with a In-Line and lowers the price target from $106 to $104.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via